Stocks and Investing Stocks and Investing
Wed, July 12, 2023
Tue, July 11, 2023

Matthew Harrison Reiterated (BLUE) at Sell and Held Target at $3 on, Jul 11th, 2023


Published on 2024-10-28 04:44:59 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Reiterated "bluebird bio, Inc." (BLUE) at Sell and Held Target at $3 on, Jul 11th, 2023.

Matthew has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Maintained at Hold with Decreased Target to $6 on, Thursday, March 30th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $8 on, Thursday, March 30th, 2023


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Gena Wang of "Barclays" Upgraded from Hold to Buy and Increased Target to $8 on, Thursday, June 1st, 2023
  • Eric Joseph of "JP Morgan" Initiated at Buy and Held Target at $7 on, Friday, April 28th, 2023